348 related articles for article (PubMed ID: 15361580)
1. Dissection of the role of MHC class II A and E genes in autoimmune susceptibility in murine lupus models with intragenic recombination.
Zhang D; Fujio K; Jiang Y; Zhao J; Tada N; Sudo K; Tsurui H; Nakamura K; Yamamoto K; Nishimura H; Shira T; Hirose S
Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13838-43. PubMed ID: 15361580
[TBL] [Abstract][Full Text] [Related]
2. Dissection of the effects of tumor necrosis factor-alpha and class II gene polymorphisms within the MHC on murine systemic lupus erythematosus (SLE).
Fujimura T; Hirose S; Jiang Y; Kodera S; Ohmuro H; Zhang D; Hamano Y; Ishida H; Furukawa S; Shirai T
Int Immunol; 1998 Oct; 10(10):1467-72. PubMed ID: 9796913
[TBL] [Abstract][Full Text] [Related]
3. Mixed haplotype A beta Z/A alpha d class II molecule in (NZB x NZW)F1 mice detected by T cell clones.
Gotoh Y; Takashima H; Noguchi K; Nishimura H; Tokushima M; Shirai T; Kimoto M
J Immunol; 1993 Jun; 150(11):4777-87. PubMed ID: 8496588
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
[TBL] [Abstract][Full Text] [Related]
5. Effects of transgenic mixed-haplotype MHC class II molecules A alpha d A beta z on autoimmune disease in New Zealand mice.
Nishimura H; Ishikawa S; Nozawa S; Awaji M; Saito J; Abe M; Tokushima M; Kimoto M; Akakura S; Tsurui H; Hirose S; Shirai T
Int Immunol; 1996 Jun; 8(6):967-76. PubMed ID: 8671686
[TBL] [Abstract][Full Text] [Related]
6. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.
Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S
Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592
[TBL] [Abstract][Full Text] [Related]
7. Analysis of MHC class II genes in the susceptibility to lupus in New Zealand mice.
Rozzo SJ; Vyse TJ; David CS; Palmer E; Izui S; Kotzin BL
J Immunol; 1999 Mar; 162(5):2623-30. PubMed ID: 10072504
[TBL] [Abstract][Full Text] [Related]
8. The BM12 mutation and autoantibodies to dsDNA in NZB.H-2bm12 mice.
Chiang BL; Bearer E; Ansari A; Dorshkind K; Gershwin ME
J Immunol; 1990 Jul; 145(1):94-101. PubMed ID: 2358682
[TBL] [Abstract][Full Text] [Related]
9. Control of separate pathogenic autoantibody responses marks MHC gene contributions to murine lupus.
Vyse TJ; Halterman RK; Rozzo SJ; Izui S; Kotzin BL
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8098-103. PubMed ID: 10393954
[TBL] [Abstract][Full Text] [Related]
10. Evidence for polyclonal T cell activation in murine models of systemic lupus erythematosus.
Rozzo SJ; Drake CG; Chiang BL; Gershwin ME; Kotzin BL
J Immunol; 1994 Aug; 153(3):1340-51. PubMed ID: 7913114
[TBL] [Abstract][Full Text] [Related]
11. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
[TBL] [Abstract][Full Text] [Related]
12. Genetic control of the spontaneous activation of CD4+ Th cells in systemic lupus erythematosus-prone (NZB x NZW) F1 mice.
Fujii T; Iida Y; Yomogida M; Ikeda K; Haga T; Jikumaru Y; Ninami M; Nishimura N; Kodera Y; Inada Y; Shirai T; Hirose S; Nishimura H
Genes Immun; 2006 Dec; 7(8):647-54. PubMed ID: 17024131
[TBL] [Abstract][Full Text] [Related]
13. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
14. Genetic association between natural autoantibody responses to histones and DNA in murine lupus.
Tokushige K; Kinoshita K; Hirose S; Shirai T
Autoimmunity; 1992; 12(4):285-93. PubMed ID: 1391598
[TBL] [Abstract][Full Text] [Related]
15. Contribution of major histocompatibility complex (MHC) to upregulation of anti-DNA antibody in transgenic mice.
Song YW; Tsao BP; Hahn BH
J Autoimmun; 1993 Feb; 6(1):1-9. PubMed ID: 8457281
[TBL] [Abstract][Full Text] [Related]
16. Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice.
Monneaux F; Dumortier H; Steiner G; Briand JP; Muller S
Int Immunol; 2001 Sep; 13(9):1155-63. PubMed ID: 11526096
[TBL] [Abstract][Full Text] [Related]
17. The contribution of I-Abm12 to phenotypic and functional alterations among T-cell subsets in NZB mice.
Naiki M; Yoshida SH; Watanabe Y; Izui S; Ansari AA; Gershwin ME
J Autoimmun; 1993 Apr; 6(2):131-43. PubMed ID: 8388689
[TBL] [Abstract][Full Text] [Related]
18. Role of the major histocompatibility complex class II Ea gene in lupus susceptibility in mice.
Ibnou-Zekri N; Iwamoto M; Fossati L; McConahey PJ; Izui S
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14654-9. PubMed ID: 9405668
[TBL] [Abstract][Full Text] [Related]
19. The immunogenetics of SLE.
Walport MJ; Black CM; Batchelor JR
Clin Rheum Dis; 1982 Apr; 8(1):3-21. PubMed ID: 6811190
[No Abstract] [Full Text] [Related]
20. [Contribution of murine models of spontaneous lupus to the analysis of genetic factors in human disease].
Tron F
Ann Med Interne (Paris); 1990; 141(3):217-21. PubMed ID: 2195946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]